Mobia Medical

Mobia Medical is a commercial-stage neurotech company that has successfully brought its first Paired VNS therapy to market for post-stroke rehabilitation. The Vivistim System is a novel, FDA-approved implantable device that delivers vagus nerve stimulation paired with physical therapy, demonstrating clinically significant improvements in arm and hand function. The company is leveraging its proprietary platform to expand into other chronic neurological conditions. With seasoned leadership from the medical device industry and a foundation in decades of neuroscience research, Mobia is positioned to grow its commercial footprint and advance its pipeline.

Paired Vagus Nerve Stimulation (Paired VNS) platform that delivers precisely timed stimulation of the vagus nerve during rehabilitative therapy to enhance neuroplasticity and strengthen new neural connections.

Mobia's Vivistim System is first-to-market with an FDA-approved implantable VNS therapy for stroke rehabilitation. It competes against traditional physical/occupational therapy, robotic-assisted devices, and other emerging neuromodulation techniques. Its primary competitive advantage is its clinically validated outcomes and proprietary pairing technology designed to directly enhance neuroplasticity.